US equities |
MU $1,073.15 ▲+2.64% NVDA $237.40 ▼-0.77% SNDK $1,714.77 ▲+3.27% AMD $644.74 ▼-0.72% SPCX $170.13 ▼-1.04% INTC $113.85 ▲+1.20% TSLA $376.06 ▼-1.21% META $723.47 ▼-2.09%
FinancialContent

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

71.95 -0.03 (-0.04%)
Delayed Quote Updated: 11:47 AM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The aggressive growth fund investor was busy adding to some of her existing positions on Thursday. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus AI: Volatility Equates to Opportunity in AI Leader ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Say Goodbye to Nancy Pelosi's Stock Picks—Here's When and Why ↗
Congresswoman and former Speaker of the House Nancy Pelosi (D-Calif.) has announced she will not seek re-election in the 2026 election and will leave the House of Representatives after her current term... 
Via Benzinga
News headline image
Tempus AI Growth Outlook Boosted By Higher ASPs, Pharma Contracts, Analyst Says ↗
Tempus AI beats Q3 revenue estimates with $334.21M, narrows adjusted loss to $0.11 per share, and raises FY25 guidance to $1.265B. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
Whitehawk Therapeutics Stock Rallies 25% On Tempus AI Collaboration Deal: Retail Hopes For A Rally Toward $5 Mark ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
From Tempus AI, Inc.
Via Business Wire
News headline image
Forecasting The Future: 10 Analyst Projections For Tempus AI ↗
 
Via Benzinga
News headline image
3 Growth Stocks to Invest $1,000 in Right Now ↗
All of them are related to artificial intelligence, but none of them are likely to be upended by the popping of any AI bubble. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus AI Stock (TEM) Slides 6% Overnight: Here's Why The Stock Is Trending ↗
Tempus AI shares fell 6.02% in after-hours trading Tuesday following its third-quarter earnings report. 
Via Benzinga
Topics Artificial Intelligence
News headline image
What's going on in today's after hours session ↗
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Tempus AI Q3 Highlights: Cathie Wood-, Nancy Pelosi-Owned AI Stock Raises Guidance ↗
Tempus AI reports Q3 revenue of $334.21M, up 84.7% YoY. It also beat EPS estimates and raises full-year revenue guidance to $1.265B. 
Via Benzinga
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Tempus Reports Third Quarter 2025 Results
From Tempus AI, Inc.
Via Business Wire
News headline image
TEMPUS AI INC (NASDAQ:TEM) Emerges as a Top Growth and Momentum Candidate ↗
Tempus AI stock shows strong technical momentum and high revenue growth, making it a top candidate for growth investors using a systematic screening method. 
Via Chartmill
Topics Artificial Intelligence
News headline image
Tempus to Participate in the Stifel 2025 Healthcare Conference
From Tempus AI, Inc.
Via Business Wire
News headline image
Ark Invest Dumps AMD Stock, Doubles Down On Chinese Tech Giants Alibaba And Baidu ↗
Cathie Wood's Ark Invest made significant trades involving BABA, BIDU, AMD, and TEM, reflecting their strategic positioning in tech. They purchased BABA and BIDU shares, while selling shares of AMD and... 
Via Benzinga
News headline image
Tempus to Report Third Quarter 2025 Financial Results on November 4
From Tempus AI, Inc.
Via Business Wire
News headline image
Why Tempus AI Stock Raced More Than 5% Higher Today ↗
The company, which specializes in artificial intelligence (AI) functionalities to aid drug discovery, could be a powerhouse, according to one market professional. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus AI Shares Are Trading Higher Monday: What's Going On? ↗
Tempus AI (NASDAQ:TEM) shares are trading higher Monday after the company announced its subsidiary, Ambry Genetics, published a peer reviewed study in Genetics in Medicine. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Beyond The Numbers: 7 Analysts Discuss Tempus AI Stock ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity
From Ambry Genetics
Via Business Wire
News headline image
AI Stocks Ride a Volatile Wave Amidst Unprecedented Growth and Bubble Fears
October 20, 2025 - The artificial intelligence (AI) sector continues to be a dominant force in the financial markets, driving significant gains and pushing major indices to new highs. Despite a... 
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
News headline image
IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio? ↗
Top large-cap losers last week included IonQ, Tempus AI, AeroVironment, Astera Labs, Nebius, Kratos, F5, Klarna, Leonardo DRS, and First Horizon, driven by sector pullbacks, policy concerns on defense... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership ↗
Whitehawk Therapeutics announced a multi-year partnership with Tempus AI, but its stock fell 8.81% in after-hours trading following the news. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Whitehawk Therapeutics Stock Is Trading Higher Thursday: What's Going On? ↗
Whitehawk Therapeutics shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI to support the development of its oncology pipeline. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Hits $100—Are Shares Due for a Pullback? ↗
After hitting $100, Tempus AI has retreated, but shares have still provided huge returns. Multiple factors suggest that the stock could see a larger correction. 
Via MarketBeat
Topics Artificial Intelligence Government Initial Public Offering
News headline image
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
From Tempus AI, Inc.
Via Business Wire
News headline image
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential. 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >